Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial.

Abstract	The effect of nonsteroid anti-inflammatory drugs (NSAIDs) after acute myocardial infarction was studied in a retrospective study of 88 patients who were receiving regular NSAID treatment at randomization in the Danish Verapamil Infarction Trial II. There were no significant differences in mortality or major events between NSAID-treated patients versus controls (1,687); however, in a multivariate analysis a nonsignificant beneficial trend in favor of NSAIDs was observed.
Authors	A Sajadieh, O Wendelboe, J F Hansen, L S Mortensen
Journal	The American journal of cardiology (Am J Cardiol) Vol. 83 Issue 8 Pg. 1263-5, A9 (Apr 15 1999) ISSN: 0002-9149 [Print] United States
PMID	10215295 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References	Anti-Inflammatory Agents, Non-Steroidal Calcium Channel Blockers Verapamil
Topics	Aged Anti-Inflammatory Agents, Non-Steroidal (therapeutic use) Calcium Channel Blockers (therapeutic use) Drug Therapy, Combination Female Follow-Up Studies Humans Male Middle Aged Myocardial Infarction (drug therapy, mortality) Prognosis Prospective Studies Safety Secondary Prevention Survival Rate Verapamil (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!